Search

First randomized evidence for kinase inhibitor activity in acute myeloid leukemia

Despite the success of tyrosine kinase inhibitors in some forms of leukemias such as chronic myeloid leukemia and acute lymphoblastic leukemia, until now a kinase inhibitor had yet to demonstrate activity in acute myeloid leukemia (AML).

Read more

Dutch scientists propose algorithm to keep drugs affordable and accessible

May 8, 2018, The Hague - An important contribution to the debate about the affordability and accessibility of innovative medicines appeared in Nature Reviews, proposing the adoption of a novel model of price setting with examples of implementation.

Read more

EHA Kick-off Grants

The call for applications will close on September 10, 2024, at 15:00 (CEST).   Apply now

The EHA Kick-off Grant is a one-year grant intended to support basic and translational early career researchers in hematology.

Read more

In Memoriam Jean Claude Brouet

Professor Jean Claude Brouet passed away on December 12, 2022 at the age of 80.

Read more

Highlights of Past EHA (HOPE) Middle East and North Africa (MENA) 2021 - report

The sixth HOPE MENA, with highlights of the EHA Annual Congress, successfully concluded September 23-24. Fully virtual for the second year in a row, the program was compiled together with eight regional partner societies.

Read more

Scientific Program Committee, EHA Congress 2024

Current committee members
Brian Huntly, United Kingdom (Chair)
Martin Dreyling, Germany (Chair elect)
Konstanze Döhner, Germany (Past Chair)
Marta Morado, Spain (Local representative)
Gabriela Baerlocher, Switzerland
Tom Cupedo, The Netherlands
Florence Cymbalista, France
Mariane De Montalembert, France
Jordi Esteve, Spain
Thoas Fioretos, Sweden
Sara Ghorashian, United Kingdom
Domenico Girelli, Italy
Mats Jerkeman, Sweden
Ulrich…

Read more